Ascendis Pharma A/S ASND:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/06/24 EDT
133.68quote price arrow down-0.32 (-0.24%)
Volume
4,940
Close
134.00UNCH (UNCH)
Volume
436,427
52 week range
83.75 - 161.00
Loading...
  • Open138.36
  • Day High138.36
  • Day Low133.53
  • Prev Close137.20
  • 52 Week High161.00
  • 52 Week High Date02/26/24
  • 52 Week Low83.75
  • 52 Week Low Date05/31/23

Key Stats

  • Market Cap7.733B
  • Shares Out57.71M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta0.60
  • YTD % Change6.39

KEY STATS

  • Open138.36
  • Day High138.36
  • Day Low133.53
  • Prev Close137.20
  • 52 Week High161.00
  • 52 Week High Date02/26/24
  • 52 Week Low83.75
  • 52 Week Low Date05/31/23
  • Market Cap7.733B
  • Shares Out57.71M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta0.60
  • YTD % Change6.39

RATIOS/PROFITABILITY

  • EPS (TTM)-9.59
  • P/E (TTM)-13.98
  • Fwd P/E (NTM)-29.38
  • EBITDA (TTM)-372.906M
  • ROE (TTM)-818.43%
  • Revenue (TTM)353.963M
  • Gross Margin (TTM)85.61%
  • Net Margin (TTM)-152.44%
  • Debt To Equity (MRQ)-280.89%

EVENTS

  • Earnings Date09/03/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ascendis Pharma A/S

 

Profile

MORE
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma...
Albert Cha M.D., Ph.D.
Independent Chairman of the Board
Jan Moller Mikkelsen
President, Chief Executive Officer, Executive Director, Member of the Executive Board
Scott Smith
Chief Financial Officer, Executive Vice President, Member of the Executive Board
Peter Rasmussen
Principal Accounting Officer, Vice President - Finance
Camilla Hartvig
Executive Vice President, Global Chief Commercial Officer
Address
Tuborg Boulevard 12
Hellerup
2900
Denmark

Top Peers

SYMBOLLASTCHG%CHG
ITCI
Intra-Cellular Therapies Inc
71.01UNCHUNCH
CERE
Cerevel Therapeutics Holdings Inc
42.52UNCHUNCH
VKTX
Viking Therapeutics Inc
78.21UNCHUNCH
ROIV
Roivant Sciences Ltd
11.60UNCHUNCH
APLS
Apellis Pharmaceuticals Inc
48.81UNCHUNCH